Description
Reg. No. G4354 (Act 36/1947)
Emulsion for injection for pigs.
INDICATIONS
For the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues, virus shedding caused by porcine circovirus type 2 (PCV2) infection, and severity of lung lesions caused by Mycoplasma hyopneumoniae infection. To reduce the loss of daily weight gain during the finishing period in face of infections with M. hyopneumoniae and/or PCV2 (as observed in field studies).
IMMUNITY
Onset of immunity with single dose vaccination:
PCV2: 2 weeks after vaccination.
M. hyopneumoniae: 4 weeks after vaccination.
Onset of immunity with repeated dose vaccination:
PCV2: 18 days after first vaccination.
M. hyopneumoniae: 3 weeks after second vaccination.
Duration of immunity both vaccination schedules:
PCV2: 22 weeks after the last vaccination.
M. hyopneumoniae: 21 weeks after the last vaccination.
COMPOSITION
Each 2 mℓ dose of inactivated emulsion vaccine contains:
Porcine circovirus type 2 ORF2 subunit antigen ≥ 2,828 AU1
M. hyopneumoniae J strain inactivated ≥ 2,69 RPU2
Adjuvants
Light mineral oil 0,268 mℓ
Aluminium (as hydroxide) 2,0 mg
1 Antigenic units as determined in the in vitro potency test (ELISA).
2 Relative potency units defined against a reference vaccine.
